Trade
Basic
Futures
Futures
Hundreds of contracts settled in USDT or BTC
Options
HOT
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Participate in events to win generous rewards
Demo Trading
Use virtual funds to experience risk-free trading
Earn
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
NEW
Trade on-chain assets and enjoy airdrop rewards!
Futures Points
NEW
Earn futures points and claim airdrop rewards
Investment
Simple Earn
Earn interests with idle tokens
Auto-Invest
Auto-invest on a regular basis
Dual Investment
Buy low and sell high to take profits from price fluctuations
Soft Staking
Earn rewards with flexible staking
Crypto Loan
0 Fees
Pledge one crypto to borrow another
Lending Center
One-stop lending hub
VIP Wealth Hub
Customized wealth management empowers your assets growth
Private Wealth Management
Customized asset management to grow your digital assets
Quant Fund
Top asset management team helps you profit without hassle
Staking
Stake cryptos to earn in PoS products
Smart Leverage
NEW
No forced liquidation before maturity, worry-free leveraged gains
GUSD Minting
Use USDT/USDC to mint GUSD for treasury-level yields
More
Innocan Pharma To Make NYSE American Debut In Early 2026
Innocan Pharma (INNPF) has announced plans to list its shares on NYSE American, with the debut targeted for January 7, 2026. The biopharmaceutical company is running a concurrent securities offering alongside this listing announcement.
Trading Timeline and Market Transitions
Currently, Innocan’s common shares are trading on OTC Markets’ OTCQB platform. This trading activity will continue through the close of business on approximately January 6, 2026. Once the NYSE American listing becomes effective, OTCQB trading will be discontinued. The transition represents a significant milestone for the company’s market positioning.
Multi-Exchange Presence
Beyond its new NYSE American listing, Innocan will maintain its Canadian market presence. The company’s shares will continue trading on the Canadian Securities Exchange under the symbol INNO. This dual-listing approach allows the pharmaceutical firm to access both U.S. and Canadian investor bases simultaneously.
About the Listing
The move to NYSE American marks a key step in Innocan Pharma’s growth trajectory. For investors tracking the company, the symbol to watch remains INNPF on its new primary exchange, while those monitoring Canadian trading can follow the INNO symbol on the Canadian Securities Exchange.